TRAX Kronos AI forecast
A 30-trading-day price forecast for First Tracks Biotherapeutics Inc. (TRAX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts First Tracks Biotherapeutics Inc. at $24.37 on 2026-12-08, −46.3% from the last close of $45.38 on 2026-10-27. Eight out of ten sampled paths end between $17.50 and $27.56, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of TRAX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $46.77 | $44.31 | $48.98 |
| 2026-11-10 | $49.24 | $40.75 | $51.79 |
| 2026-11-17 | $32.78 | $23.37 | $42.97 |
| 2026-11-24 | $30.09 | $21.55 | $38.74 |
| 2026-12-01 | $25.78 | $22.51 | $33.12 |
| 2026-12-08 | $24.37 | $17.50 | $27.56 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for TRAX?
- Kronos AI's median forecast for TRAX is $24.37 in 30 trading days, −46.3% from the last close, with a 10–90% range of $17.50 to $27.56.
- Is the TRAX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC